Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase (302 views visite)
Biochem Medica (ISSN: 1330-0962), 2016; 26(1): 114-120.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 2.934, 5-year impact factor Impact factor a 5 anni: 3.522
Url: https://www2.scopus.com/inward/record.uri?eid=2-s2.0-84957883605&partnerID=40&md5=41eb878b0d2ac69cc1460bd2abc4a9e8
Keywords Parole chiave: Biomarker, Colorectal Cancer, M2-Type Pyruvate Kinase, Occult Blood, Screening,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Medical Sciences, University of Turin, Turin, Italy
Centro di Prevenzione Oncologica (CPO Piemonte), AOU Città della Salute e della Scienza, Turin, Italy
Institute for Biostructures and Bioimages-CNR c/o Molecular Biotechnology Center, University of Turin, Turin, Italy
References Riferimenti:
Zubero, M.B., Arana-Arri, E., Pijoan, J.I., Portillo, I., Idigoras, I., Lopez-Urrutia, A., Population-based colorectal cancer screening: Comparison of two fecal occult blood test (2014) Front Pharmacol, 4, p. 175. , http://dx.doi.org/10.3389/fphar.2013.0017
Fraser, C.G., Rubeca, T., Rapi, S., Chen, L.S., Chen, H.H., Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening (2014) Clin Chem Lab Med, 52, pp. 1211-1216. , http://dx.doi.org/10.1515/cclm-2014-0115
Paska, A.V., Hudler, P., Aberrant methylation patterns in cancer: A clinical view (2015) Biochem Med (Zagreb), 25, pp. 161-176. , http://dx.doi.org/10.11613/BM.2015.017
Senore, C., Reggio, D., Musso, A., Bruno, M., De Angelis, C., Giordanino, C., Narrow band imaging vs. High definition colonoscopy for detection of colorectal adenomas in patients with positive faecal occult blood test: A randomized trial (2014) Dig Liver Dis, 46, pp. 803-807. , http://dx.doi.org/10.1016/j.dld.2014.05.007
Von Karsa, L., Patnick, J., Segnan, N., Atkin, W., Halloran, S., Lansdorp-Vogelaar, I., European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication (2013) Endoscopy, 45, pp. 51-59
Tonus, C., Sellinger, M., Koss, K., Neupert, G., Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis (2012) World J Gastroenterol, 18, pp. 4004-4011. , http://dx.doi.org/10.3748/wjg.v18.i30.4004
Mazurek, S., Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells (2011) Int J Biochem Cell Biol, 43, pp. 969-980. , http://dx.doi.org/10.1016/j.biocel.2010.02.005
Hardt, P.D., Toepler, M., Ngoumou, B., Rupp, J., Kloer, H.U., Measurement of fecal pyruvate kinase type M2 (Tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls (2003) Anticancer Res, 23, pp. 851-853
Abdullah, M., Rani, A.A., Simadibrata, M., Fauzi, A., Syam, A.F., The value of fecal tumor M2 pyruavte kinase as diagnostic tool for colorectal cancer screening (2012) Acta Med Indones, 44, pp. 94-99
Leen, R., Seng-Lee, C., Holleran, G., O’Morain, C., McNamara, D., Comparison of faecal M2-PK and FIT in a population based bowel cancer screening cohort (2014) Eur J Gastroenterol Hepatol, 26, pp. 514-518. , http://dx.doi.org/10.1097/MEG.0000000000000025
Fraser, C.G., Halloran, S.P., Allison, J.E., Young, G.P., Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT) (2013) Clin Chim Lab Med, 51, pp. 2056-2067. , http://dx.doi.org/10.1515/cclm-2013-0408
Fraser, C.G., Allison, J.E., Halloran, S.P., Young, G.P., A proposal to standardize reporting units for faecal immunochemical tests for haemoglobin (2012) J Natl Cancer Inst, 104, pp. 810-814. , http://dx.doi.org/10.1093/jnci/djs190
Hamilton, S., Aaltonene, L., (2000) Pathology and Genetics. Tumours of the Digestive System, , World Health Organization classification of tumours 2nd ed Lyon: International Agency for research on Cancer
Segnan, N., Senore, C., Reoni, B., Azzoni, A., Bisanti, L., Cardelli, A., Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening (2007) Gastroenterology, 132, pp. 2304-2312. , http://dx.doi.org/10.1053/j.gastro.2007.03.030
Shastri, Y.M., Naumann, M., Oremek, G.M., Hanisch, E., Rosch, W., Mossner, J., Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia (2006) Int J Cancer, 119, pp. 2651-2656. , http://dx.doi.org/10.1002/ijc.22243
Shastri, Y.M., Loitsch, S., Hoepffner, N., Povse, N., Hanisch, E., Rosch, W., Comparison of an established simple officebased immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: Prospective multicenter study (2008) Am J Gastroenterol, 103, pp. 1496-1504. , http://dx.doi.org/10.1111/j.1572-0241.2008.01824.x
Parente, F., Marino, B., Ilardo, A., Fracasso, P., Zullo, A., Hassan, C., A combination of faecal tests for the detection of colon cancer: A new strategy for appropriate selection of referrals to colonoscopy? A prospective multicenter Italian study (2012) Eur J Gastroenterol Hepatol, 24, pp. 1145-1152. , http://dx.doi.org/10.1097/MEG.0b013e328355cc79
Kim, Y.C., Kim, J.H., Cheung, D.Y., Kim, T.H., Jun, E.J., Oh, J.W., The usefulness of a novel screening kit for colorectal cancer using the immunochromatographic fecal tumor M2 pyruvate kinase test (2015) Gut Liver, 9, pp. 641-648. , http://dx.doi.org/10.5009/gnl13457
Zorzi, M., De’ Bianchi, P.S., Grazzini, G., Senore, C., Gruppo di lavoro sugli indicatori del GISCoR. Quality indicators for the evaluation of colorectal cancer screening programs (2007) Epidemiol Prev, 31, pp. 6-56
Koss, K., Maxton, D., Jankowski, J.A.Z., Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention (2008) Colorectal Dis, 10, pp. 244-248. , http://dx.doi.org/10.1111/j.1463-1318.2007.01334.x
Biochem Medica (ISSN: 1330-0962), 2016; 26(1): 114-120.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 2.934, 5-year impact factor Impact factor a 5 anni: 3.522
Url: https://www2.scopus.com/inward/record.uri?eid=2-s2.0-84957883605&partnerID=40&md5=41eb878b0d2ac69cc1460bd2abc4a9e8
Keywords Parole chiave: Biomarker, Colorectal Cancer, M2-Type Pyruvate Kinase, Occult Blood, Screening,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Medical Sciences, University of Turin, Turin, Italy
Centro di Prevenzione Oncologica (CPO Piemonte), AOU Città della Salute e della Scienza, Turin, Italy
Institute for Biostructures and Bioimages-CNR c/o Molecular Biotechnology Center, University of Turin, Turin, Italy
References Riferimenti:
Zubero, M.B., Arana-Arri, E., Pijoan, J.I., Portillo, I., Idigoras, I., Lopez-Urrutia, A., Population-based colorectal cancer screening: Comparison of two fecal occult blood test (2014) Front Pharmacol, 4, p. 175. , http://dx.doi.org/10.3389/fphar.2013.0017
Fraser, C.G., Rubeca, T., Rapi, S., Chen, L.S., Chen, H.H., Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening (2014) Clin Chem Lab Med, 52, pp. 1211-1216. , http://dx.doi.org/10.1515/cclm-2014-0115
Paska, A.V., Hudler, P., Aberrant methylation patterns in cancer: A clinical view (2015) Biochem Med (Zagreb), 25, pp. 161-176. , http://dx.doi.org/10.11613/BM.2015.017
Senore, C., Reggio, D., Musso, A., Bruno, M., De Angelis, C., Giordanino, C., Narrow band imaging vs. High definition colonoscopy for detection of colorectal adenomas in patients with positive faecal occult blood test: A randomized trial (2014) Dig Liver Dis, 46, pp. 803-807. , http://dx.doi.org/10.1016/j.dld.2014.05.007
Von Karsa, L., Patnick, J., Segnan, N., Atkin, W., Halloran, S., Lansdorp-Vogelaar, I., European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication (2013) Endoscopy, 45, pp. 51-59
Tonus, C., Sellinger, M., Koss, K., Neupert, G., Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis (2012) World J Gastroenterol, 18, pp. 4004-4011. , http://dx.doi.org/10.3748/wjg.v18.i30.4004
Mazurek, S., Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells (2011) Int J Biochem Cell Biol, 43, pp. 969-980. , http://dx.doi.org/10.1016/j.biocel.2010.02.005
Hardt, P.D., Toepler, M., Ngoumou, B., Rupp, J., Kloer, H.U., Measurement of fecal pyruvate kinase type M2 (Tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls (2003) Anticancer Res, 23, pp. 851-853
Abdullah, M., Rani, A.A., Simadibrata, M., Fauzi, A., Syam, A.F., The value of fecal tumor M2 pyruavte kinase as diagnostic tool for colorectal cancer screening (2012) Acta Med Indones, 44, pp. 94-99
Leen, R., Seng-Lee, C., Holleran, G., O’Morain, C., McNamara, D., Comparison of faecal M2-PK and FIT in a population based bowel cancer screening cohort (2014) Eur J Gastroenterol Hepatol, 26, pp. 514-518. , http://dx.doi.org/10.1097/MEG.0000000000000025
Fraser, C.G., Halloran, S.P., Allison, J.E., Young, G.P., Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT) (2013) Clin Chim Lab Med, 51, pp. 2056-2067. , http://dx.doi.org/10.1515/cclm-2013-0408
Fraser, C.G., Allison, J.E., Halloran, S.P., Young, G.P., A proposal to standardize reporting units for faecal immunochemical tests for haemoglobin (2012) J Natl Cancer Inst, 104, pp. 810-814. , http://dx.doi.org/10.1093/jnci/djs190
Hamilton, S., Aaltonene, L., (2000) Pathology and Genetics. Tumours of the Digestive System, , World Health Organization classification of tumours 2nd ed Lyon: International Agency for research on Cancer
Segnan, N., Senore, C., Reoni, B., Azzoni, A., Bisanti, L., Cardelli, A., Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening (2007) Gastroenterology, 132, pp. 2304-2312. , http://dx.doi.org/10.1053/j.gastro.2007.03.030
Shastri, Y.M., Naumann, M., Oremek, G.M., Hanisch, E., Rosch, W., Mossner, J., Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia (2006) Int J Cancer, 119, pp. 2651-2656. , http://dx.doi.org/10.1002/ijc.22243
Shastri, Y.M., Loitsch, S., Hoepffner, N., Povse, N., Hanisch, E., Rosch, W., Comparison of an established simple officebased immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: Prospective multicenter study (2008) Am J Gastroenterol, 103, pp. 1496-1504. , http://dx.doi.org/10.1111/j.1572-0241.2008.01824.x
Parente, F., Marino, B., Ilardo, A., Fracasso, P., Zullo, A., Hassan, C., A combination of faecal tests for the detection of colon cancer: A new strategy for appropriate selection of referrals to colonoscopy? A prospective multicenter Italian study (2012) Eur J Gastroenterol Hepatol, 24, pp. 1145-1152. , http://dx.doi.org/10.1097/MEG.0b013e328355cc79
Kim, Y.C., Kim, J.H., Cheung, D.Y., Kim, T.H., Jun, E.J., Oh, J.W., The usefulness of a novel screening kit for colorectal cancer using the immunochromatographic fecal tumor M2 pyruvate kinase test (2015) Gut Liver, 9, pp. 641-648. , http://dx.doi.org/10.5009/gnl13457
Zorzi, M., De’ Bianchi, P.S., Grazzini, G., Senore, C., Gruppo di lavoro sugli indicatori del GISCoR. Quality indicators for the evaluation of colorectal cancer screening programs (2007) Epidemiol Prev, 31, pp. 6-56
Koss, K., Maxton, D., Jankowski, J.A.Z., Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention (2008) Colorectal Dis, 10, pp. 244-248. , http://dx.doi.org/10.1111/j.1463-1318.2007.01334.x
Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase
Introduction: Screening programs for colorectal cancer (CRC) are mainly based on a first-line fecal immunochemical test for hemoglobin (FIT). Fecal M2-type pyruvate kinase (M2-PK) has been evaluated in clinical settings showing promising results for early CRC detection. However, the impact of fecal M2-PK assessment on the performance of first-round CRC screening programs is not known. We investigated whether fecal M2-PK alone or in combination with FIT may improve CRC screening efficacy in the general population. Materials and methods: A total of 1027 asymptomatic subjects (median age 66 [59-74] years; females 504 [49.1%]), identified through the general practitioners' rosters, were invited for the collection of 2 fecal samples for FIT and M2-PK evaluation. Participants with at least positive one fecal test were referred for colonoscopy. Quality indicators for screening performance were calculated and analyzed using Fisher's exact test. Results: Overall, 572 subjects underwent both FIT and M2-PK assessment (participation rate 55.7%): 93 participants showed positive results for at least one test (positivity rate 16.3%). Only 10 patients were positive for both tests. Attendance rate to colonoscopy was 86.0% and a total of 65 adenomas and 7 cancers were detected. Combined use of FIT and fecal M2-PK permitted the identification of 18 more neoplasm (25%) without improving colonoscopy workload, as deduced by the comparable number needed to scope (P = 0.402). Conclusion: The addition of M2-PK testing to FIT offers the potential to detect additional neoplasms that either do not bleed or only bleed intermittently without reducing participation rate and without increasing endoscopy workload. © Croatian Society of Medical Biochemistry and Laboratory Medicine.
Introduction: Screening programs for colorectal cancer (CRC) are mainly based on a first-line fecal immunochemical test for hemoglobin (FIT). Fecal M2-type pyruvate kinase (M2-PK) has been evaluated in clinical settings showing promising results for early CRC detection. However, the impact of fecal M2-PK assessment on the performance of first-round CRC screening programs is not known. We investigated whether fecal M2-PK alone or in combination with FIT may improve CRC screening efficacy in the general population. Materials and methods: A total of 1027 asymptomatic subjects (median age 66 [59-74] years; females 504 [49.1%]), identified through the general practitioners' rosters, were invited for the collection of 2 fecal samples for FIT and M2-PK evaluation. Participants with at least positive one fecal test were referred for colonoscopy. Quality indicators for screening performance were calculated and analyzed using Fisher's exact test. Results: Overall, 572 subjects underwent both FIT and M2-PK assessment (participation rate 55.7%): 93 participants showed positive results for at least one test (positivity rate 16.3%). Only 10 patients were positive for both tests. Attendance rate to colonoscopy was 86.0% and a total of 65 adenomas and 7 cancers were detected. Combined use of FIT and fecal M2-PK permitted the identification of 18 more neoplasm (25%) without improving colonoscopy workload, as deduced by the comparable number needed to scope (P = 0.402). Conclusion: The addition of M2-PK testing to FIT offers the potential to detect additional neoplasms that either do not bleed or only bleed intermittently without reducing participation rate and without increasing endoscopy workload. © Croatian Society of Medical Biochemistry and Laboratory Medicine.
Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase
No results. Nessun risultato. |
Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase
Manco M, Ala U, Cantarella D, Tolosano E, Medico E, Altruda F, Fagoonee S
* The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells (2 visite)
Cancers (ISSN: 2072-6694linking), 2021 Aug 13; 13(16): N/D-N/D.
Impact Factor: 6.126
Dettagli Esporta in BibTeX Esporta in EndNote
Susana F, Fagoonee S, Alessandro S, Valentina G, Chiara R, Marco P, Fiorella A, Danilo D
* Impedance-based drug-resistance characterization of colon cancer cells through real-time cell culture monitoring (71 visite)
Talanta (ISSN: 0039-9140linking), 2021 Jan 15; 222: 121441-121441.
Impact Factor: 5.339
Dettagli Esporta in BibTeX Esporta in EndNote
D'Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G, Tatangelo F, Tafuto S, Portella L, Santagata S, Nasti G, Ottaiano A, Pacelli R, Delrio P, Botti G, Scala S
* New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer (120 visite) (PDF 35 visite)
Cancers (ISSN: 2072-6694linking), 2020 Jul 18; 12(7): 1952-1952.
Impact Factor: 6.126
Dettagli Esporta in BibTeX Esporta in EndNote
Ala U, Manco M, Mandili G, Tolosano E, Novelli F, Provero P, Altruda F, Fagoonee S
* Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells (109 visite)
Int J Mol Sc (ISSN: 1422-0067linking, 1661-6596, 1422-0067electronic), 2020 Jan 16; 21 (2 ): N/D-N/D.
Impact Factor: 2.598
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A
* Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (123 visite)
World J Gastroentero (ISSN: 1007-9327linking, 2219-2840), 2019 Sep 21; 25 (35 ): 5233-5256.
Impact Factor: 2.24
Dettagli Esporta in BibTeX Esporta in EndNote
Barresi V, Valenti G, Spampinato G, Musso N, Castorina S, Rizzarelli E, Condorelli DF
* Transcriptome analysis reveals an altered expression profile of zinc transporters in colorectal cancer (168 visite)
J Cell Biochem (ISSN: 0730-2312linking), 2018 Dec; 119(12): 9707-9719.
Impact Factor: 2.959
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Simonetti I, Tarotto L, Trovato P, Mainolfi CG, Salvatore B, Pace L
* 18-F-FDG PET, PET/CT AND MDCT IN LOCALLY ADVANCED COLORECTAL CANCER (152 visite) (PDF 154 visite)
Int J Of Current Res, 2017 Jul; 9: 53960-53964.
Impact Factor: 7.086
Dettagli Esporta in BibTeX Esporta in EndNote
Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfo I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F
* The RNA-binding protein ESRP1 promotes human colorectal cancer progression (321 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2016 Dec 28; 8(6): 10007-10024.
Impact Factor: 5.168
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Romano F, Pizzuti L, Segreto S, Storto G, Mannelli L, Imbriaco M, Camera L, Maurea S
* Non-invasive diagnostic imaging of colorectal liver metastases (231 visite)
World J Radiol (ISSN: 1949-8470electronic, 1949-8470linking), 2015 Jul 28; 7(7): 157-169.
Impact Factor: 0.567
Dettagli Esporta in BibTeX Esporta in EndNote
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ
* Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer (271 visite)
N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756.
Impact Factor: 59.558
Dettagli Esporta in BibTeX Esporta in EndNote
Greco A, D'Alterio C, Auletta L, Albanese S, Napolitano M, Portella L, Santagata S, Ierano C, Brunetti A, Scala S, Zannetti A
* Longitudinal evaluation with High Frequency Ultrasound imaging of response to CXCR4 new cyclic peptide antagonist with conventional chemotherapy in colorectal cancer mice model (358 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42: S425-S425.
Impact Factor: 5.537
Dettagli Esporta in BibTeX Esporta in EndNote
Cicatiello V, Apicella I, Tudisco L, Tarallo V, Formisano L, Sandomenico A, Kim Y, Bastos-Carvalho A, Orlandi A, Ambati J, Ruvo M, Bianco R, de Falco S
* Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models (375 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic, 1949-2553linking), 2015; 6(12): 10563-10576.
Impact Factor: 5.008
Dettagli Esporta in BibTeX Esporta in EndNote
Napolitano S, Troiani T, Morgillo F, Ciardiello F, Belli G, Cioffi L, Sirignano C, Martinelli E
* Predictive Biomarkers To Anti-Egfr Inhibitors Treatment In The Management Of Metastatic Colorectal Cancer (216 visite) (PDF 7 visite)
Journal Of Carcinogenesis & Mutagenesis, 2014; N/D: 2157-2518.
Impact Factor: 3.445
Dettagli Esporta in BibTeX Esporta in EndNote
Giacomobono S, Gallicchio R, Capacchione D, Nardelli A, Gattozzi D, Lettini G, Molinari L, Mainenti P, Cammarota A, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (267 visite)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 2013 Jul 12; 28(12): 1699-1705.
Impact Factor: 2.415
Dettagli Esporta in BibTeX Esporta in EndNote
Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (556 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L
* Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging? (300 visite)
World J Gastroentero (ISSN: 2219-2840, 1007-9327, 1007-9327linking), 2011 Mar 21; 17(11): 1427-1433.
Impact Factor: 2.471
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M
* Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1. 5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents (378 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2010 Oct; 35(5): 511-521.
Impact Factor: 1.95
Dettagli Esporta in BibTeX Esporta in EndNote
Capaccio D, Ciccodicola A, Sabatino L, Casamassimi A, Pancione M, Fucci A, Febbraro, Merlino A, Graziano G, Colantuoni V
* A novel germline mutation in Peroxisome Proliferator-Activated Receptor γ gene associated with large intestine polyp formation and dyslipidemia (384 visite)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2010; 1802(6): 572-581.
Impact Factor: 2.773
Dettagli Esporta in BibTeX Esporta in EndNote
Giacomobono S, Capacchione D, Lancellotti M, Nardelli A, Gallicchio R, Improta G, Nappi A, Cammarota A, Di Leo A, Pace L, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (217 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Nicolai E, Salvatore M
* [18F]FDG-PET-CT for early monitoring of tumor response: When and why (341 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009 Apr; 53(2): 167-180.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, Simeone R, Fonti R, Marciano R, Bianco R, Damiano V, Tortora G, Pace L, Del Vecchio S, Salvatore M
* 18F-FDG PET/CT in the assessment of early response to chemotherapy and molecularly targeted agents in metastatic colorectal cancer (221 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Cirillo LC, Camera L, Persico F, Cantalupo T, Pace L, De Palma GD, Persico G, Salvatore M
* Accuracy of single phase contrast enhanced multidetector CT colonography in the preoperative staging of colo-rectal cancer (297 visite)
Eur J Radiol (ISSN: 0720-048x), 2006 Dec; 60(3): 453-459.
Impact Factor: 1.332
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Cantalupo T, Mainenti PP, Mainolfi CG, Varrone A, Salvatore B, Persico F, D'Antonio D, Pace L, Salvatore M
* 18F-fdg pet, pet/ct and ce-mdct in locally advanced colorectal cancer (242 visite) (PDF 154 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Mainenti PP, Varrone A, Mainolfi C, Salvatore B, Caprio MG, Cella L, Soricelli A, Pace L, Salvatore M
* Role of FDG-PET/CT in the staging of colorectal cancer (261 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
De Renzo A, Perna F, Persico M, Mainolfi C, Pace L
* 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma (212 visite)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2006 Jun; 133(6): 580-580.
Impact Factor: 4.498
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Romano M, Imbriaco M, Camera L, Pace L, D'Antonio D, Bucci L, Galloro G, Salvatore M
* Added value of CT colonography after a positive conventional colonoscopy: Impact on treatment strategy (336 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2005 Jan; 30(1): 42-47.
Impact Factor: 1.034
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (254 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (2515 visite)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
28 Records (23 escludendo Abstract e Conferenze).
Impact factor totale: 156.337 (134.694 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 131.518 (108.298 escludendo Abstract e Conferenze).
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Manco M, Ala U, Cantarella D, Tolosano E, Medico E, Altruda F, Fagoonee S
* The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells (2 visite)
Cancers (ISSN: 2072-6694linking), 2021 Aug 13; 13(16): N/D-N/D.
Impact Factor: 6.126
Dettagli Esporta in BibTeX Esporta in EndNote
Susana F, Fagoonee S, Alessandro S, Valentina G, Chiara R, Marco P, Fiorella A, Danilo D
* Impedance-based drug-resistance characterization of colon cancer cells through real-time cell culture monitoring (71 visite)
Talanta (ISSN: 0039-9140linking), 2021 Jan 15; 222: 121441-121441.
Impact Factor: 5.339
Dettagli Esporta in BibTeX Esporta in EndNote
D'Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G, Tatangelo F, Tafuto S, Portella L, Santagata S, Nasti G, Ottaiano A, Pacelli R, Delrio P, Botti G, Scala S
* New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer (120 visite) (PDF 35 visite)
Cancers (ISSN: 2072-6694linking), 2020 Jul 18; 12(7): 1952-1952.
Impact Factor: 6.126
Dettagli Esporta in BibTeX Esporta in EndNote
Ala U, Manco M, Mandili G, Tolosano E, Novelli F, Provero P, Altruda F, Fagoonee S
* Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells (109 visite)
Int J Mol Sc (ISSN: 1422-0067linking, 1661-6596, 1422-0067electronic), 2020 Jan 16; 21 (2 ): N/D-N/D.
Impact Factor: 2.598
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A
* Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (123 visite)
World J Gastroentero (ISSN: 1007-9327linking, 2219-2840), 2019 Sep 21; 25 (35 ): 5233-5256.
Impact Factor: 2.24
Dettagli Esporta in BibTeX Esporta in EndNote
Barresi V, Valenti G, Spampinato G, Musso N, Castorina S, Rizzarelli E, Condorelli DF
* Transcriptome analysis reveals an altered expression profile of zinc transporters in colorectal cancer (168 visite)
J Cell Biochem (ISSN: 0730-2312linking), 2018 Dec; 119(12): 9707-9719.
Impact Factor: 2.959
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Simonetti I, Tarotto L, Trovato P, Mainolfi CG, Salvatore B, Pace L
* 18-F-FDG PET, PET/CT AND MDCT IN LOCALLY ADVANCED COLORECTAL CANCER (152 visite) (PDF 154 visite)
Int J Of Current Res, 2017 Jul; 9: 53960-53964.
Impact Factor: 7.086
Dettagli Esporta in BibTeX Esporta in EndNote
Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfo I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F
* The RNA-binding protein ESRP1 promotes human colorectal cancer progression (321 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2016 Dec 28; 8(6): 10007-10024.
Impact Factor: 5.168
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Romano F, Pizzuti L, Segreto S, Storto G, Mannelli L, Imbriaco M, Camera L, Maurea S
* Non-invasive diagnostic imaging of colorectal liver metastases (231 visite)
World J Radiol (ISSN: 1949-8470electronic, 1949-8470linking), 2015 Jul 28; 7(7): 157-169.
Impact Factor: 0.567
Dettagli Esporta in BibTeX Esporta in EndNote
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ
* Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer (271 visite)
N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756.
Impact Factor: 59.558
Dettagli Esporta in BibTeX Esporta in EndNote
Greco A, D'Alterio C, Auletta L, Albanese S, Napolitano M, Portella L, Santagata S, Ierano C, Brunetti A, Scala S, Zannetti A
* Longitudinal evaluation with High Frequency Ultrasound imaging of response to CXCR4 new cyclic peptide antagonist with conventional chemotherapy in colorectal cancer mice model (358 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42: S425-S425.
Impact Factor: 5.537
Dettagli Esporta in BibTeX Esporta in EndNote
Cicatiello V, Apicella I, Tudisco L, Tarallo V, Formisano L, Sandomenico A, Kim Y, Bastos-Carvalho A, Orlandi A, Ambati J, Ruvo M, Bianco R, de Falco S
* Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models (375 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic, 1949-2553linking), 2015; 6(12): 10563-10576.
Impact Factor: 5.008
Dettagli Esporta in BibTeX Esporta in EndNote
Napolitano S, Troiani T, Morgillo F, Ciardiello F, Belli G, Cioffi L, Sirignano C, Martinelli E
* Predictive Biomarkers To Anti-Egfr Inhibitors Treatment In The Management Of Metastatic Colorectal Cancer (216 visite) (PDF 7 visite)
Journal Of Carcinogenesis & Mutagenesis, 2014; N/D: 2157-2518.
Impact Factor: 3.445
Dettagli Esporta in BibTeX Esporta in EndNote
Giacomobono S, Gallicchio R, Capacchione D, Nardelli A, Gattozzi D, Lettini G, Molinari L, Mainenti P, Cammarota A, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (267 visite)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 2013 Jul 12; 28(12): 1699-1705.
Impact Factor: 2.415
Dettagli Esporta in BibTeX Esporta in EndNote
Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (556 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L
* Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging? (300 visite)
World J Gastroentero (ISSN: 2219-2840, 1007-9327, 1007-9327linking), 2011 Mar 21; 17(11): 1427-1433.
Impact Factor: 2.471
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M
* Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1. 5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents (378 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2010 Oct; 35(5): 511-521.
Impact Factor: 1.95
Dettagli Esporta in BibTeX Esporta in EndNote
Capaccio D, Ciccodicola A, Sabatino L, Casamassimi A, Pancione M, Fucci A, Febbraro, Merlino A, Graziano G, Colantuoni V
* A novel germline mutation in Peroxisome Proliferator-Activated Receptor γ gene associated with large intestine polyp formation and dyslipidemia (384 visite)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2010; 1802(6): 572-581.
Impact Factor: 2.773
Dettagli Esporta in BibTeX Esporta in EndNote
Giacomobono S, Capacchione D, Lancellotti M, Nardelli A, Gallicchio R, Improta G, Nappi A, Cammarota A, Di Leo A, Pace L, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (217 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Nicolai E, Salvatore M
* [18F]FDG-PET-CT for early monitoring of tumor response: When and why (341 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009 Apr; 53(2): 167-180.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, Simeone R, Fonti R, Marciano R, Bianco R, Damiano V, Tortora G, Pace L, Del Vecchio S, Salvatore M
* 18F-FDG PET/CT in the assessment of early response to chemotherapy and molecularly targeted agents in metastatic colorectal cancer (221 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Cirillo LC, Camera L, Persico F, Cantalupo T, Pace L, De Palma GD, Persico G, Salvatore M
* Accuracy of single phase contrast enhanced multidetector CT colonography in the preoperative staging of colo-rectal cancer (297 visite)
Eur J Radiol (ISSN: 0720-048x), 2006 Dec; 60(3): 453-459.
Impact Factor: 1.332
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Cantalupo T, Mainenti PP, Mainolfi CG, Varrone A, Salvatore B, Persico F, D'Antonio D, Pace L, Salvatore M
* 18F-fdg pet, pet/ct and ce-mdct in locally advanced colorectal cancer (242 visite) (PDF 154 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Mainenti PP, Varrone A, Mainolfi C, Salvatore B, Caprio MG, Cella L, Soricelli A, Pace L, Salvatore M
* Role of FDG-PET/CT in the staging of colorectal cancer (261 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
De Renzo A, Perna F, Persico M, Mainolfi C, Pace L
* 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma (212 visite)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2006 Jun; 133(6): 580-580.
Impact Factor: 4.498
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Romano M, Imbriaco M, Camera L, Pace L, D'Antonio D, Bucci L, Galloro G, Salvatore M
* Added value of CT colonography after a positive conventional colonoscopy: Impact on treatment strategy (336 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2005 Jan; 30(1): 42-47.
Impact Factor: 1.034
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (254 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (2515 visite)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
28 Records (23 escludendo Abstract e Conferenze).
Impact factor totale: 156.337 (134.694 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 131.518 (108.298 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Gennaro Angrisano on in data Sunday 12 July 2020, 13:14:47
302 views visite. Last view on Ultima visita in data Tuesday 21 September 2021, 20:52:09
ibb.cnr.it